Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma

BACKGROUND: Although systemic corticosteroid (SCS) treatment, irrespective of duration or dosage, is associated with adverse outcomes for patients with asthma, the longitudinal effects of this treatment on adverse outcomes, healthcare resource utilization (HCRU), and healthcare costs are unknown. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Voorham, Jaco, Xu, Xiao, Price, David B., Golam, Sarowar, Davis, Jill, Zhi Jie Ling, Joanna, Kerkhof, Marjan, Ow, Mandy, Tran, Trung N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587525/
https://www.ncbi.nlm.nih.gov/pubmed/29987879
http://dx.doi.org/10.1111/all.13556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587525/
https://www.ncbi.nlm.nih.gov/pubmed/29987879
http://dx.doi.org/10.1111/all.13556

Ejemplares similares